Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link. All three major indices are trading down today with the Dow Jones Industrial Average ( ^DJI) trading down 41 points (-0.3%) at 14,800 as of Friday, Aug. 30, 2013, 12:50 PM ET. The NYSE advances/declines ratio sits at 850 issues advancing vs. 2,040 declining with 117 unchanged. The Banking industry currently sits down 0.7% versus the S&P 500, which is down 0.3%. TheStreet would like to highlight 4 stocks pushing the industry higher today: 4. Banco Santander Chile ( BSAC) is one of the companies pushing the Banking industry higher today. As of noon trading, Banco Santander Chile is up $0.52 (2.4%) to $22.08 on average volume. Thus far, 200,259 shares of Banco Santander Chile exchanged hands as compared to its average daily volume of 294,400 shares. The stock has ranged in price between $21.46-$22.09 after having opened the day at $21.58 as compared to the previous trading day's close of $21.56. Banco Santander-Chile provides commercial and retail banking services in Chile. It operates through two segments, Commercial Banking, and Global Banking and Markets. Banco Santander Chile has a market cap of $10.2 billion and is part of the financial sector. Shares are down 24.3% year to date as of the close of trading on Thursday. Currently there is 1 analyst that rates Banco Santander Chile a buy, 1 analyst rates it a sell, and 4 rate it a hold. TheStreet Ratings rates Banco Santander Chile as a hold. The company's strengths can be seen in multiple areas, such as its expanding profit margins and notable return on equity. However, as a counter to these strengths, we also find weaknesses including a generally disappointing performance in the stock itself and unimpressive growth in net income. Get the full Banco Santander Chile Ratings Report now. 3x UPSIDE POTENTIAL: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.